The Biomanufacturing Viral Detection and Quantification Market Size is valued at 466.52 Million in 2022 and is predicted to reach 981.41 Million by the year 2031 at a 8.8% CAGR during the forecast period for 2023-2031.
Viral clearance is necessary during the downstream purification of therapeutic biologics, blood, and tissue-derived materials. Viruses are either removed or inactivated for manufacturing microbiologically stable goods.
Reliable and fast viral detection and quantification techniques are required to advance basic research and clinical approaches. The biomanufacturing viral detection and quantification market is estimated to be driven by technological advancements in the viral testing domain and the increasing demand for biopharmaceutical products.
Due to the increasing utilization of biopharmaceuticals, the biomanufacturing viral detection and quantification market is growing rapidly. Quality control systems are essential to ensure biopharmaceuticals' safety, efficacy and consistency. This increases the demand for consumables and equipment for the identification & quantification of viral contaminants in the biomanufacturing process of biological products, thereby promoting the growth of the biomanufacturing viral detection and quantification market.
The Biomanufacturing Viral Detection and Quantification Market is segmented based on offering type, technology, application, and end user. The offering type segment includes consumables, instruments, and services. By technology, the market is bifurcated into PCR, ELISA, flow cytometry, plaque assay, and others. By application, the market is categorized into blood and blood products manufacturing, vaccines and therapeutics manufacturing, cellular and gene therapy products manufacturing, stem cell products manufacturing, and tissue and tissue products manufacturing. Based on end user, the market is divided into life science companies, testing laboratories, CROs and CDMOs.
Based on offering type, the consumables segment dominated the biomanufacturing viral detection and quantification market in 2022. The surging adoption of kits, assays, monitoring and additional equipment has led to a significant increase in the consumables segment. Consumables are products and materials that are continuously used throughout the viral detection and quantification process. Many consumables are used in viral testing to determine the quantity or concentration of a particular virus in biological samples.
By Technology, PCR Technology Segment is expected to grow at the highest rate in the biomanufacturing viral detection and quantification market during the forecast period.
Virus detection and testing using polymerase chain reaction (PCR) technology has the advantage of high sensitivity and reproducibility. PCR testing can identify the development of the infection, monitor the response to treatment, and distinguish latent from active infection. Also, in virus monitoring, PCR assays help identify false positive results caused by inadvertent contamination of samples with traces of viral nucleic acids or PCR products.
Based on application, the biomanufacturing viral detection and quantification market was led by the blood and blood products manufacturing segment in 2022. Viral testing identifies and measures viral nucleic acids in blood samples and helps maintain the safety and quality of blood & blood products.
In terms of end users, the life science companies segment dominated the biomanufacturing viral detection and quantification market in 2022.
Maintaining quality control measures in the life sciences industries is crucial to manufacturing products with high safety, quality and efficiency. Viral detection and quantification methods are used at the drug/therapy development, production, and testing stages.
North America held the largest share of the biomanufacturing viral detection and quantification market in 2022 and is predicted to continue its trend over the forecast period, owing to the presence of most key players, increased demand for cell & gene therapies, advancements in viral detection and quantification technologies. Furthermore, the Asia Pacific market is expected to accelerate over the projected period (2023-2031), owing to the continuous R&D efforts in the viral detection and quantification industry, the high utilization of biopharmaceutical products, and the rising funding for innovative therapy research.
|
Report Attribute |
Specifications |
|
Market Size Value In 2022 |
USD 466.52 Million |
|
Revenue Forecast In 2031 |
USD 981.41 Million |
|
Growth Rate CAGR |
CAGR of 8.8 % from 2023 to 2031 |
|
Quantitative Units |
Representation of revenue in US$ Million and CAGR from 2023 to 2031 |
|
Historic Year |
2019 to 2022 |
|
Forecast Year |
2023-2031 |
|
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
|
Segments Covered |
By Offering Type, Technology, Application, End User |
|
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; The UK; France; Italy; Spain; China; Japan; India; South Korea; South East Asia; South Korea; South East Asia |
|
Competitive Landscape |
Danaher Corporation, Merck KGaA, New England Biolabs, TAKARA HOLDINGS INC., Thermo Fisher Scientific Inc., Agilent Technologies, Inc., Sartorius AG, Charles River Laboratories, Bio-Rad Laboratories, Inc., PerkinElmer, Inc., Promega Corporation, QIAGEN N.V., Genscript Biotech Corporation, Norgen Biotek Corp., and others. |
|
Customization Scope |
Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing and Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Biomanufacturing Viral Detection and Quantification Market Snapshot
Chapter 4. Global Biomanufacturing Viral Detection and Quantification Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis of Metaverse Industry
4.6. Industry Analysis – Porter’s Five Forces Analysis
4.7. COVID-19 Impact on Metaverse Industry
Chapter 5. Market Segmentation 1: By Offering Type Estimates & Trend Analysis
5.1. By Offering Type & Market Share, 2019-2031
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2031 for the following By Offering Type :
5.2.1. Consumables
5.2.2. Instruments
5.2.2.1. Kits and Assays
5.2.2.2. Accessories
5.2.3. Services
Chapter 6. Market Segmentation 2: By Technology Estimates & Trend Analysis
6.1. By Offering Type & Market Share, 2019-2031
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2031 for the following By Technology:
6.2.1. PCR
6.2.2. ELISA
6.2.3. Flow Cytometry
6.2.4. Plaque Assay
6.2.5. Others
Chapter 7. Market Segmentation 3: By Application Estimates & Trend Analysis
7.1. By Offering Type & Market Share, 2019-2031
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2031 for the following By Application:
7.2.1. Blood and Blood Products Manufacturing
7.2.2. Vaccines and Therapeutics Manufacturing
7.2.3. Cellular and Gene Therapy Products Manufacturing
7.2.4. Stem Cell Products Manufacturing
7.2.5. Tissue and Tissue Products Manufacturing
Chapter 8. Market Segmentation 4: By End user Estimates & Trend Analysis
8.1. By Offering Type & Market Share, 2019-2031
8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2031 for the following By End user:
8.2.1. Life Science Companies
8.2.2. Testing Laboratories
8.2.3. CROs and CDMOs
Chapter 9. Biomanufacturing Viral Detection and Quantification Market Segmentation 5: Regional Estimates & Trend Analysis
9.1. North America
9.1.1. North America Biomanufacturing Viral Detection and Quantification Market revenue (US$ Million) estimates and forecasts By Offering Type, 2023-2031
9.1.2. North America Biomanufacturing Viral Detection and Quantification Market revenue (US$ Million) estimates and forecasts By Technology, 2023-2031
9.1.3. North America Biomanufacturing Viral Detection and Quantification Market revenue (US$ Million) estimates and forecasts By Application, 2023-2031
9.1.4. North America Biomanufacturing Viral Detection and Quantification Market revenue (US$ Million) estimates and forecasts By, End User 2023-2031
9.1.5. North America Biomanufacturing Viral Detection and Quantification Market revenue (US$ Million) estimates and forecasts by country, 2023-2031
9.1.5.1. U.S.
9.1.5.2. Canada
9.2. Europe
9.2.1. Europe Biomanufacturing Viral Detection and Quantification Market revenue (US$ Million) By Offering Type, 2023-2031
9.2.2. Europe Biomanufacturing Viral Detection and Quantification Market revenue (US$ Million) estimates and forecasts By Technology, 2023-2031
9.2.3. Europe Biomanufacturing Viral Detection and Quantification Market revenue (US$ Million) estimates and forecasts By Application 2023-2031
9.2.4. Europe Biomanufacturing Viral Detection and Quantification Market revenue (US$ Million) estimates and forecasts By End user,2023-2031
9.2.5. Europe Biomanufacturing Viral Detection and Quantification Market revenue (US$ Million) by country, 2023-2031
9.2.5.1. Germany
9.2.5.2. Poland
9.2.5.3. France
9.2.5.4. Italy
9.2.5.5. Spain
9.2.5.6. UK
9.2.5.7. Rest of Europe
9.3. Asia Pacific
9.3.1. Asia Pacific Biomanufacturing Viral Detection and Quantification Market revenue (US$ Million) by By Offering Type, 2023-2031
9.3.2. Asia Pacific Biomanufacturing Viral Detection and Quantification Market revenue (US$ Million) estimates and forecasts By Technology, 2023-2031
9.3.3. Asia Pacific Biomanufacturing Viral Detection and Quantification Market revenue (US$ Million) estimates and forecasts By Application, 2023-2031
9.3.4. Asia Pacific Biomanufacturing Viral Detection and Quantification Market revenue (US$ Million) estimates and forecasts By End user, 2023-20
9.3.5. Asia Pacific Biomanufacturing Viral Detection and Quantification Market revenue (US$ Million) by country, 2023-2031
9.3.5.1. China
9.3.5.2. India
9.3.5.3. Japan
9.3.5.4. Australia
9.3.5.5. Rest of Asia Pacific
9.4. Latin America
9.4.1. Latin America Biomanufacturing Viral Detection and Quantification Market revenue (US$ Million) by By Offering Type, 2023-2031
9.4.2. Latin America Biomanufacturing Viral Detection and Quantification Market revenue (US$ Million) estimates and forecasts By Technology, 2023-2031
9.4.3. Latin America Biomanufacturing Viral Detection and Quantification Market revenue (US$ Million) estimates and forecasts By Application, 2023-2031
9.4.4. Latin America Biomanufacturing Viral Detection and Quantification Market revenue (US$ Million) estimates and forecasts By End user, 2023-2031
9.4.5. Latin America Biomanufacturing Viral Detection and Quantification Market revenue (US$ Million) by country, (US$ Million) 2023-2031
9.4.5.1. Brazil
9.4.5.2. Rest of Latin America
9.5. Middle East & Africa
9.5.1. Middle East & Africa Biomanufacturing Viral Detection and Quantification Market revenue (US$ Million) by By Offering Type, (US$ Million)
9.5.2. Middle East & Africa Biomanufacturing Viral Detection and Quantification Market revenue (US$ Million) estimates and forecasts By Technology, 2023-2031
9.5.3. Middle East & Africa Biomanufacturing Viral Detection and Quantification Market revenue (US$ Million) estimates and forecasts By Application, 2023-2031
9.5.4. Middle East & Africa Biomanufacturing Viral Detection and Quantification Market revenue (US$ Million) estimates and forecasts By End user, 2023-2031
9.5.5. Middle East & Africa Biomanufacturing Viral Detection and Quantification Market revenue (US$ Million) by country, (US$ Million) 2023-2031
9.5.5.1. South Africa
9.5.5.2. GCC Countries
9.5.5.3. Rest of MEA
Chapter 10. Competitive Landscape
10.1. Major Mergers and Acquisitions/Strategic Alliances
10.2. Company Profiles
10.2.1. Danaher Corporation
10.2.2. Merck KGaA
10.2.3. TAKARA HOLDINGS INC.
10.2.4. Thermo Fisher Scientific Inc.
10.2.5. Agilent Technologies, Inc.
10.2.6. Sartorius AG
10.2.7. Charles River Laboratories
10.2.8. Bio-Rad Laboratories, Inc.
10.2.9. PerkinElmer, Inc.
10.2.10. Promega Corporation
10.2.11. QIAGEN N.V.
10.2.12. Genscript Biotech Corporation
10.2.13. Norgen Biotek Corp.
10.2.14. New England Biolabs
10.2.15. Other Prominent Players
Biomanufacturing Viral Detection and Quantification Market By Offering Type-
Biomanufacturing Viral Detection and Quantification Market By Technology-
Biomanufacturing Viral Detection and Quantification Market By Application-
Biomanufacturing Viral Detection and Quantification Market By End User-
Biomanufacturing Viral Detection and Quantification Market By Region-
North America-
Europe-
Asia-Pacific-
Latin America-
Middle East & Africa-
InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.
Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.
Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.
Secondary research
The secondary research sources that are typically mentioned to include, but are not limited to:
The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista
Primary Research:
Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies
The contributors who typically take part in such a course include, but are not limited to:
Data Modeling and Analysis:
In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.
The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.
To know more about the research methodology used for this study, kindly contact us/click here.
